INTERLEUKIN-1-ALPHA AND INTERLEUKIN-BETA AUGMENT PULMONARY-ARTERY TRANSENDOTHELIAL ALBUMIN FLUX INVITRO

Human recombinant interleukin-1-alpha (rIL-1-alpha) and -beta were studied to determine whether either could alter the permeability of bovine pulmonary artery endothelial cell monolayers. Endothelial cells were grown to confluence on filters mounted in chemotaxis chambers placed in wells. Barrier function of the monolayers was assessed by placing C-14-labeled bovine serum albumin ([C-14]BSA) in the upper chamber and sampling the lower well for [C-14]BSA. rIL-1-alpha induced a significant (P < 0.01) dose- and time-dependent increase in transendothelial [C-14]BSA flux. rIL-1-alpha exposures as brief as 30 min increased permeability,but the increased albumin transfer could not be demonstrated before 4 h after exposure. Exposures up to 6 h were reversible at 24 h. rIL-1-alpha induced significantly (P < 0.01) greater increments in [C-14]BSA flux than did equivalent exposures to rIL-1-beta. No important differences between bovine and human rIL-1-beta were demonstrated. Increased transendothelial flux could not be ascribed to either endothelial cytotoxicity or growth inhibition. There was no additive or synergistic relationship between rIL-1-alpha and human recombinant tumor necrosis factor-alpha. Our studies suggest that IL-1-alpha and -beta may play a role in the pathogenesis of pulmonary vascular leak.